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The hypothesis of the study is that Torsades de pointes (TdP) history can be better identified using T-wave morphology compared to Fridericia-corrected QT interval (QTcF) at baseline. ECGs were recorded at baseline and during sotalol challenge in 20 patients with a history of TdP (1TdP) and 16 patients without previous TdP (-TdP). The QTcF and T-wave morphology combination score (MCS) were calculated. At baseline, there was no significant difference in QTcF between the groups (1TdP: QTcF 5 446 6 9 ms; -TdP: QTcF 5 431 6 9 ms, P 5 0.27). In contrast, MCS was significantly different between the groups at baseline (1TdP: MCS 5 1.07 6 0.095; -TdP: MCS 5 0.74 6 0.07, P 5 0.012). Both QTcF and MCS could be used to discriminate between 1TdP and -TdP after sotalol but only MCS reached statistical significance at baseline. Combining QTcF with MCS provided a significantly larger difference between groups than QTcF alone.
Study Highlights WHAT IS THE CURRENT KNOWLEDGE OF THE TOPIC?
þ Patients with a history of TdP are prone to drug-induced repolarization disturbance that can trigger TdP. A latent abnormality in repolarization is primarily measured in the ECG as a prolongation of the QT interval. However, using the QT interval alone it is difficult to identify vulnerable patients without stress testing.
WHAT QUESTION DID THIS STUDY ADDRESS?
þ The study investigated if T-wave morphology (MCS) can aid in identifying vulnerable patients at risk of TdP.
WHAT THIS STUDY ADDS TO OUR KNOWLEDGE
þ At baseline, without the need for stress testing, T-wave morphology but not QTc can be used to identify vulnerable patients with a history of TdP (1TdP) and patients without such history (-TdP). HOW THIS MIGHT CHANGE CLINICAL PHARMA-COLOGY OR TRANSLATIONAL SCIENCE þ T-wave morphology analysis can be used as an adjunct to QTcF measurements to stratify patients for TdP risk without drug challenge.
Drug-induced repolarization abnormalities put vulnerable patients at risk of Torsades de pointes (TdP) and sudden cardiac death (SCD). 1 Drugs that inhibit the rapidly activating component of the delayed rectifier potassium current in the myocardium (IKr) manifest in the ECG by prolonging the QT interval, which has been associated with drug-induced TdP and SCD.
2 A drug-induced QTc prolongation (QT corrected for changes in heart rate) of less than 5 ms is unlikely to induce TdP, whereas prolongations greater than 20 ms are associated with substantially higher risk. 3 In addition, the risk of TdP increases exponentially at a rate of 5% with every 10 ms prolongation of QTc beyond 440 ms. 4 However, the relation between the prolongation of QTc and proarrhythmic risk is not straightforward. QTc is a mediocre parameter for assessing risk of drug-induced TdP and there are a number of QTc prolonging drugs with very limited or no proarrhythmic history. For instance, moxifloxacin, [5] [6] [7] tamoxifen, 8 and ranolazine 9 prolong the QTc interval without causing arrhythmia. These observations challenge the QTc-based drug safety screening and recent studies suggest that repolarization abnormalities can be assessed with a higher degree of precision with other electrocardiographic markers. [10] [11] [12] [13] Several markers based on the properties of the T-wave have been proposed. The interval between the peak of the T-wave and the end of the T-wave (TpTe) has received significant attention. The T-wave right slope in lead I was found to improve the detection of patients with a history of TdP if used in combination with QTc. 13 A prolonged TpTe interval has been associated with a risk of TdP during acquired bradyarrhythmia when notched Twaves are present. 15 TpTe also failed to distinguish the symptomatic and asymptomatic patients in congenital long QT syndrome. 16 Moreover, TpTe correlates strongly with QT and thus does not add new information to the QT interval, the latter remaining the preferred marker. 17 T-wave alternans was also suggested as a proarrhythmic risk marker: It was observed just prior to episodes of TdP. 18 Area-based markers of the T-wave, such as Relative T-wave Area (RTA), attained their maxima just before the onset of TdP in dogs treated with sertindole. 19 A systematic quantification of Twave morphology as defined by Graff et al. 10, 11 combines three features of T-wave morphology: asymmetry, flatness, and notch into a composite score termed the Morphology Combination Score (MCS). MCS was shown to be a robust parameter that may improve drug safety studies, for example in cases where the QT interval and some other T-wave morphology markers show false-positive results. 11, 20 Several markers, including MCS parameters, early repolarization duration (ERD), and late repolarization duration (LRD) of the T-wave loop, QRS-t angle, spatial ventricular gradient, and total cosine R-to-T were analyzed by Vicente et al. 12 in a study using dofetilide, quinidine, ranozil, and verapimil. The study showed that the morphological parameters effectively identified pure hERG blocking, whereas interval analyses may reveal additional sodium and calcium channel blocking that might reduce the torsadogenic risk of a drug.
Patients with a history of TdP (1TdP) have altered repolarization and, therefore, respond more to IKr-inhibiting drugs in terms of QTc interval than patients without such history (-TdP). 21 The baseline QTc values in those two groups of patients suggest that abnormal repolarization is normally masked, and hence stressing that patients with, e.g., sotalol, is required to unmask any an existing repolarization disturbance. In this study we investigated if the T-wave morphology parameter MCS can be used to identify the 1TdP patients and -TdP patients at baseline and after sotalol challenge, with QTc as the reference measure.
RESULTS

Study sample
The clinical characteristics of the patients are shown in Table 1 . There was no significant difference between the average ages of the 1TdP and -TdP groups: 1 TdP 59 6 12 and -TdP 62 6 12 years (P 5 0.59). The 1 TdP group consisted of 11 males and 9 females and the -TdP were 5 males and 11 females. Two-way analysis of variance (ANOVA) tests, at baseline and at the time of maximum response, showed that the results are independent of the different male:female ratios in the groups considering both MCS (Baseline: P 5 0.24; Maximum response: P 5 0.84) and QTcF (Baseline: P 5 0.59; Maximum response: P 5 0.79) and the interaction between patients' sex and the presence of the history of drug-induced TdP was not statistically significant.
QTcF and MCS
The difference in QTcF at baseline between the 1TdP and -TdP groups was not statistically significant ( Table 2) . Five patients had a QTcF duration above a gender-specific QTcF threshold for LQTS (QTcF >470 ms in men and QTcF >480 ms in women), 22 which comprised four patients (three male 1 one female) from the 1 TdP group and one patient (one female) from the -TdP group. Table 2 shows the baseline values and sotalol-induced changes in the two groups.
The QTcF value attained its maximum at 20 min after completion of the drug infusion for both groups. The mean difference between the QTcF values for the 1TdP and -TdP groups at this time was 51.4 ms (P 5 0.0018).
In contrast to QTcF, at baseline the difference (0.33) in MCS between the groups was statistically significant (P 5 0.01). The maximum values of MCS occurred about 20 min after completion of the drug infusion for both groups. The mean difference in MCS between the groups at this timepoint was 0.38 (P 5 0.037).
Representative ECGs indicating prominent QT interval prolongation and T-wave changes during the sotalol infusion (0, 5, 10, 15, and 20 min) from both the 1 TdP and -TdP groups are shown in Figure 1 . During the drug infusion period of 20 min and during about 20 min after completion of the infusion, the QT interval increased from baseline for both groups. The corresponding changes in the T-wave morphology are associated with increased asymmetry, flatness, and notching.
The averages of QTcF and MCS for each 5-minute segment during the whole experimental period (up to 20 min after infusion) are presented in Figure 2 , with error bars indicating the 95% confidence intervals (CIs). QTcF increased more in patients with a history of TdP as compared with the patients in the -TdP group (P < 0.017). In contrast, the change in the T-wave morphology was similar in the two groups (P 5 0.73).
Identification of patients with a history of TdP
A linear discriminant analysis 23 was used to identify the 1TdP and -TdP patients based on QTcF and/or MCS values at baseline and at 20 min after completion of the sotalol infusion. Table 3 shows the sensitivity (Se), specificity (Sp), positive predictivity (PP), and negative predictivity (NP) for the univariate (discriminant analysis based on QTcF and MCS separately) and covariate cases (discriminant analysis considering both QTcF and MCS). McNemar's test showed that a combined method, using QTcF and MCS, provides a significantly higher accuracy (0.69) of correct identification of patients compared with QTcF-only (accuracy 5 0.50) based identification at baseline (P 5 0.04).
DISCUSSION
Administering IKr-inhibiting drugs to patients with a history of TdP poses substantial risk of arrhythmogenesis, as evident from their postdose QTcF values. From the analyses of K€ a€ ab et al. 21 and Couderc et al., 24 it is evident that the QTcF at baseline was not significantly different between the 1TdP and -TdP groups, which corroborates our QTcF finding. After the sotalol infusion, the 1TdP group responded with significantly higher QTcF than the -TdP group. K€ a€ ab et al. 21 reported the higher postdose QTcF of the 1TdP group as compared with the -TdP group as the unmasking of the reduced repolarization reserve of the former group. The repolarization reserve by definition is a defensive mechanism against the triggering of TdP as a result of the interaction of other ion channels. 25 However, the association between drug-induced repolarization changes and the so-called repolarization reserve is not clear. We do not have measures to quantify and relate the repolarization reserve with ECG parameters. Nevertheless, the higher QTcF of the 1TdP group can be assumed to reflect their abnormality in repolarization, which agrees with the observations of Sauer et al., that higher baseline QTc was associated with discontinuation of sotalol and dofetilide. 26 Stress testing has been established as a way to unmask the presence of LQTS. 27 The higher postdose QTcF of the 1TdP group implies the need for a stress test to find patients with latent repolarization disturbance. In contrast, MCS already at baseline identifies repolarization disturbances with similar accuracy as stress testing with QTcF, thus implying that a combination of QTc and MCS at baseline could eliminate the need for provocative stress testing.
QTcF-based correct identification of patients in their respective groups (1TdP or -TdP) increased after drug treatment (baseline: 9 postdose: 14), as shown in Table 3 . However, this accuracy can be already attained at baseline when both the baseline QTcF and MCS were used in the discriminant analysis. On the other hand, there is no significant difference between the number of correct identifications by MCS at baseline (n 5 12) and by QTcF after sotalol treatment (n 5 14). Hence, again it can be inferred that the combination of the baseline values of QTcF and MCS may be used to avoid stress testing.
Other T-wave based parameter, e.g., the T-loop morphology analysis by Couderc et al. 24 on the data of similar groups, also shows the differences between groups. A difference in ERD between the groups was significant at baseline but not significant after sotalol treatment. On the other hand, LRD showed the exact opposite response-being similar in the two groups at baseline and significantly different after sotalol. This transition of the significance of early and late repolarization duration is interesting, although the reason for it is unclear. The TpTe between the groups was not significantly different at baseline, although it attained a significant level after the sotalol treatment, but with very high standard deviation, which might not be clinically useful for identifying individual vulnerable patients. 24 Also, TpTe/QTc was not significantly different between the groups, either at baseline or after sotalol. 24 However, some other measures related to the risk of TdP may be investigated in future studies. The Index of Cardio-Electrophysiological Balance (iCEB 5 QRS/QT), 28, 29 QTinstability, 30 and the electro-mechanical window (EMW) 31, 32 have shown some potential with respect to QT-prolongation and the risk of TdP, although EMW would require an echocardiography in addition to the ECG.
We found a larger mean QT interval prolongation after sotalol in the 1TdP group compared to the -TdP group. This differential QT effect highlights another problem related to potential wrongful labeling of the risk associated with a drug. A QT-based risk assessment of TdP is obtained from a thorough QT (TQT) study carried out in healthy volunteers. The study is used to assess whether or not a drug will have a QT interval-prolonging effect in the target population. However, it has never been demonstrated that QT interval data from TQT trials in healthy volunteers can be extrapolated to the target population to identify repolarization effects reliably. In fact, our QT results suggest the opposite. Extrapolation to the clinical situation based on QT labeling may, therefore, be inappropriate and wrong. On the other hand, MCS is a stable parameter and the mean baseline MCS of the -TdP patients (0.74) and of the healthy volunteers from another sotalol study by Graff et al. 11 (0.71) are interestingly similar. Furthermore, we emphasize our observation that sotalol had similar effects on T-wave morphology in the 1TdP and -TdP groups and propose further studies to be carried out to investigate if T-wave morphology changes are more consistent across different patient populations than QT interval changes.
The results of this study suggest that T-wave morphology is an indicator of risk of TdP and that the standard QT analysis should be enriched with analysis of T-wave morphology in patients with suspected pro-arrhythmic tendencies or for screening of patients to be treated with QT-prolonging drugs such as Class III antiarrhytmics. 
METHODS
Study population
The ECG data were obtained from patients with paroxysmal atrial fibrillation (AF) and was available from the Medical Center of the University of Munich, Germany. The 1 TdP group (n 5 20) was defined as patients with a documented history of TdP in association with QTprolonging drugs. The -TdP group (n 5 16) consists of patients who were treated with sotalol for their paroxysmal AF and without a history of TdP. All of the patients were informed about the study and gave signed consent for the study, which was approved by the local Ethics Committee of the university and the procedures were followed accordingly.
Study protocol
The protocol was described by K€ a€ ab et al. 21 In short, all patients rested in supine position for 60-90 min prior to testing. Tests were performed between 9:00 and 13:00, and dl-sotalol was infused at a constant rate over a 20-min interval at a dose of 2 mg/kg body weight in both groups. All the patients were closely monitored in the ICU from 1 h before to 24 h after testing. Digital 12-lead ECGs were recorded as nine consecutive 5-min segments while the patients were in a supine position, at baseline (one ECG segment), during intravenous sotalol infusion of 20 min (four ECG segments), and the 20 min steady-state phase just after discontinuing sotalol infusion (four ECG segments).
ECG analysis
Median beat formation. The central 3 min of each of the 5-min ECG segments were used to derive 18 median beats in each lead of the 12-lead 10-sec recordings in that 3-min period. The MUSE/Interval Editor software (GE Healthcare, Milwaukee, WI) was used to form the median beats. QT-interval and T-wave morphology parameters were calculated from the first principal component of each of the 18 median beats. The resulting 18 values were subsequently averaged for each 5-min segment.
QT and T-wave morphology measurement. The QT interval was measured using the tangent method described by Lepeschkin and Surawicz 33 and corrected for heart rate with Fridericia's formula to give QTcF.
The details of the morphology measurement were presented by Graff et al. 11, 20 In brief; the morphology measure is a combination of the measures of T-wave asymmetry, flatness, and notching.
Asymmetry was defined as the average squared difference in the slope profiles of the ascending and descending part of the T-wave (see Figure 3a for a normal symmetric T-wave and 3b for an asymmetric T-wave).
Flatness was calculated as a modified version of the standard kurtosis measure which is used to describe the peakedness of a probability distribution (Figure 3c has a flatter T-wave than 3a and 3b).
The notch in the T-wave was quantified by the depth of the nadir near the peak of the T-wave. The magnitude of a notch was measured on a unit amplitude T-wave and assigned to one of three categories: no notch 5 0, moderate notch (perceptible bulge) 5 0.5, and pronounced notch 5 1.0 (distinct protuberance above the apex). Figure 3D shows a notch in the T-wave.
The morphology measures were linearly combined to yield the MCS as a measure of the overall description of the T-wave morphology.
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ECG measurements were calculated before unblinding of data.
Statistical analysis
As some of the ECG segments were missing at random, a standard method (Expectation Maximization algorithm (EM) 34 ) was used to account for the missing values in the statistical analysis. All analyses were done in SPSS (IBM SPSS Statistics 21, Chicago, IL). A 2-way ANOVA was used to account for potential bias due to the different male:female ratios between the groups. An independent sample t-test was performed to calculate the significance of the differences at baseline and after sotalol infusion between the groups. Linear discriminant analysis was used as a measure of distinction between 1TdP and -TdP. A McNemar test was used for the classification of 1TdP and -TdP groups. P < 0.05 was considered significant. Results are presented as mean 6 standard error (SE) unless otherwise stated.
Limitations of the study
The sample size in this study was small (n 5 36), although it contained ample ECG data (45 min) from each patient. Both groups consisted of patients with paroxysmal AF and according to Hong et al., 35 AF has a shortening effect on the QT interval, which indicates that the results might be different for different heart diseases.
The dosage was a single infusion of sotalol, which does not affect the results at baseline, but with repeated administration of the drug the results may develop differently over time.
The automatic calculation of the QT interval is a possible source of error. To mitigate this problem, we manually evaluated the resulting QRS-start and T-end points on the ECGs without finding errors requiring overreading, although the tangent method as such systematically underestimates the QT interval.
Several interesting parameters have been proposed in the literature. In the current study we investigated QTc and MCS only. The results encourage future study with other promising parameters. 
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